Literature DB >> 10214108

Identifying infectious diseases in prisons: surveillance, protection, and intervention.

M C White.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10214108      PMCID: PMC1305539     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  3 in total

Review 1.  HIV risk reduction and service delivery strategies in criminal justice settings.

Authors:  J A Inciardi
Journal:  J Subst Abuse Treat       Date:  1996 Sep-Oct

2.  Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system.

Authors:  J D Ruiz; F Molitor; R K Sun; J Mikanda; M Facer; J M Colford; G W Rutherford; M S Ascher
Journal:  West J Med       Date:  1999-03

3.  Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.

Authors:  J B Wong; W G Bennett; R S Koff; S G Pauker
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

  3 in total
  3 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan.

Authors:  Abdul M Kazi; Sharaf A Shah; Cathy A Jenkins; Bryan E Shepherd; Sten H Vermund
Journal:  Int J Infect Dis       Date:  2010-03-01       Impact factor: 3.623

3.  Serological markers and risk factors associated with Hepatitis B virus infection among Federal Capital Territory prison inmates, Nigeria: Should we be concerned?

Authors:  Chioma Cindy Dan-Nwafor; Ikeola Adeoye; Kehinde Aderemi; Martins Onuoha; Elizabeth Adedire; Adebobola Bashorun; Damaris Osunkwo; Saheed Gidado; Muhammad Balogun; Suleiman Idris; Ibrahim Ade-Yusuf; Ekpedeme Udom; Patrick Nguku
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.